Total planned funding: $985,351,129
Clear active filters
Chemonics International
HTXD: Treatment: ARV Drugs
Private Contractor
2010
2011
2012
2013
2014
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $223,768,941 |
Tanzania | $218,473,833 |
Zambia | $163,166,925 |
Mozambique | $73,884,612 |
Uganda | $62,938,876 |
Zimbabwe | $60,747,053 |
Democratic Republic of the Congo | $42,595,035 |
Rwanda | $35,774,246 |
Haiti | $33,880,077 |
Vietnam | $18,962,593 |
Côte d'Ivoire | $18,371,101 |
Eswatini | $11,621,595 |
Ukraine | $11,405,290 |
Burundi | $3,438,296 |
West Africa Region | $2,012,397 |
South Sudan | $1,791,212 |
Namibia | $1,075,000 |
Lesotho | $482,041 |
Botswana | $331,279 |
Western Hemisphere Region | $309,202 |
Asia Regional Program | $175,500 |
Cameroon | $146,025 |
Organizational Types
Private Contractor | $985,351,129 |
Program Areas
Treatment | $985,351,129 |
Budget Codes
HTXD: Treatment: ARV Drugs | $985,351,129 |
Top Partner Programs
Chemonics International:
$985,351,129
View countries